Organon & Co. — Director's Dealing 2021

Aug 19, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Organon & Co. (OGN)
CIK: 0001821825
Period of Report: 2021-08-17

Reporting Person: Ali Kevin (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-17	Stock Option (Right to Buy)	$35.38	A	133928	Acquired	2031-08-16	Common Stock (133928)	Direct

Footnotes

F1: The option vests and becomes exercisable in three equal installments on August 17, 2022, August 17, 2023 and August 17, 2024.